Research New Data on AramcholTM for the Treatment of Non-alcoholic Steatohepatitis: Exploring Potential for Greater Efficacy and the Effect on Glucose Metabolism RachelFebruary 8, 2021
Research Past, present and future perspectives in nonalcoholic fatty liver disease RachelDecember 28, 2020
Research Galmed and Gannex Expand Development Programs For NASH Through Research Collaboration of Aramchol and ASC41 (THR-beta Agonist) RachelNovember 30, 2020
Research NASH is an Inflammatory Disorder: Pathogenic, Prognostic and Therapeutic Implications RachelOctober 19, 2020
